| 1/3 | US=16 / Tórax Felip E, Baselga J. Lung cancer biology: receptor tyrosine kinase abnormalities in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 147-59. ISBN 0-7817-4620-5. NEOPLASIAS PULMONARES; RECEPTOR DE TIROSINA QUINASE; ANORMALIDADES; HISTOLOGIA; RECEPTORES DO FATOR DE CRESCIMENTO EPIDERMICO |
| 2/3 | US=16 / Tórax Dowell J, Gazdar AF, Shigematsu H, Herz J, Minna JD. Lung cancer biology: clinical and biologic implications of EGFR mutations in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 172-7. ISBN 0-7817-4620-5. ONCOGENE; MUTACOES EGFR; NEOPLASIA PULMONAR; RECEPTOR DE TIROSINA QUINASE; INIBIDORES DE TIROSINA QUINASE; MUTACAO DE TIROSINA QUINASE |
| 3/3 | US=22-C / Câncer Davies MA, Garraway LA. Biologia molecular do melanoma cutâneo. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 1337-1345. ISBN 978-1-45119294-0. QUINASE RAF; MEK 1/2; NF1; CDKN2A; INK4A; CDK4; CCND1; RB1; AKT; RECEPTOR DE TIROSINA QUINASE; REGULADOR DO CICLO CELULAR; MITF; MC1R; TELOMERASE; GENETICA MOLECULAR DO MELANOMA |